Frontiers | Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward
CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes | Science Advances
CAR T cells: Building on the CD19 paradigm - Globerson Levin - 2021 - European Journal of Immunology - Wiley Online Library
Lymphoma Development in Pten L/L Ship L/L Cd19 Cre Mice Occurs in a... | Download Scientific Diagram
Cancers | Free Full-Text | Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy
CAR T cells: Building on the CD19 paradigm - Globerson Levin - 2021 - European Journal of Immunology - Wiley Online Library
Percentages of CD4 + IL10 + T cells and CD19 + IL10 + B cells increase,... | Download Scientific Diagram
Characteristics of iKP-19-CAR-T cells and CD19-CAR-T cells.... | Download Scientific Diagram
Reduced peripheral blood regulatory B cell levels are not associated with the Expanded Disability Status Scale score in multiple sclerosis - Shujun Guo, Qingqing Chen, Xiaoli Liang, Mimi Mu, Jing He, Qiang
Frontiers | Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma
Normal B-cell ranges in infants: A systematic review and meta-analysis - ScienceDirect
Immunophenotypic changes in leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia after treatment with CD19-directed chimeric antigen receptor (CAR)- expressing T cells | Haematologica
TCR+/BCR+ dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes - ScienceDirect
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection | Leukemia
Cancers | Free Full-Text | Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy
Cells | Free Full-Text | Flow Cytometric Methods for the Detection of Intracellular Signaling Proteins and Transcription Factors Reveal Heterogeneity in Differentiating Human B Cell Subsets
Immunophenotypic changes in leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia after treatment with CD19-directed chimeric antigen receptor (CAR)- expressing T cells | Haematologica
Clinical overview of anti-CD19 BiTE® and ex vivo data from anti-CD33 BiTE® as examples for retargeting T cells in hematologic malignancies - ScienceDirect
Cytofluorimetric assay to investigate variability in blinatumomab in vitro response
15‐color highly sensitive flow cytometry assay for post anti‐CD19 targeted therapy (anti‐CD19‐CAR‐T and blinatumomab) measurable residual disease assessment in B‐lymphoblastic leukemia/lymphoma: Real‐world applicability and challenges - Chatterjee ...
CD19 Monoclonal Antibody (SJ25-C1), PE-Alexa Fluor™ 610 (MHCD1922)
Frontiers | Gut Antibody Deficiency in a Mouse Model of CVID Results in Spontaneous Development of a Gluten-Sensitive Enteropathy
ExCellerate B Cell Media, Xeno-Free (CCM031): R&D Systems®
